BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 15509164)

  • 41. Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives. Part 2.
    Tseng CH; Tzeng CC; Yang CL; Lu PJ; Chen HL; Li HY; Chuang YC; Yang CN; Chen YL
    J Med Chem; 2010 Aug; 53(16):6164-79. PubMed ID: 20662543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and cytotoxic activity of a new series of topoisomerase I inhibitors.
    Dallavalle S; Gattinoni S; Mazzini S; Scaglioni L; Merlini L; Tinelli S; Beretta GL; Zunino F
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1484-9. PubMed ID: 18248813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cellular topoisomerase I inhibition and antiproliferative activity by MJ-III-65 (NSC 706744), an indenoisoquinoline topoisomerase I poison.
    Antony S; Kohlhagen G; Agama K; Jayaraman M; Cao S; Durrani FA; Rustum YM; Cushman M; Pommier Y
    Mol Pharmacol; 2005 Feb; 67(2):523-30. PubMed ID: 15531731
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bisindenoisoquinoline bis-1,3-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline)-6-propylamino}propane bis(trifluoroacetate) (NSC 727357), a DNA intercalator and topoisomerase inhibitor with antitumor activity.
    Antony S; Agama KK; Miao ZH; Hollingshead M; Holbeck SL; Wright MH; Varticovski L; Nagarajan M; Morrell A; Cushman M; Pommier Y
    Mol Pharmacol; 2006 Sep; 70(3):1109-20. PubMed ID: 16798938
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 2,4,6-Trisubstituted pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
    Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong BS; Jeong TC; Lee CS; Lee ES
    Bioorg Med Chem; 2007 Jul; 15(13):4351-9. PubMed ID: 17493824
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and antitumor activity of the hexacyclic camptothecin derivatives.
    Gao H; Zhang X; Chen Y; Shen H; Pang T; Sun J; Xu C; Ding J; Li C; Lu W
    Bioorg Med Chem Lett; 2005 Jul; 15(13):3233-6. PubMed ID: 15913996
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel synthetic isoquinolino[5,4-ab]phenazines: inhibition toward topoisomerase I, antitumor and DNA photo-cleaving activities.
    Yang P; Yang Q; Qian X; Cui J
    Bioorg Med Chem; 2005 Nov; 13(21):5909-14. PubMed ID: 16115776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and cytotoxic activity of polyamine analogues of camptothecin.
    Dallavalle S; Giannini G; Alloatti D; Casati A; Marastoni E; Musso L; Merlini L; Morini G; Penco S; Pisano C; Tinelli S; De Cesare M; Beretta GL; Zunino F
    J Med Chem; 2006 Aug; 49(17):5177-86. PubMed ID: 16913706
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and topoisomerase II inhibitory and cytotoxic activity of oxiranylmethoxy- and thiiranylmethoxy-chalcone derivatives.
    Na Y; Nam JM
    Bioorg Med Chem Lett; 2011 Jan; 21(1):211-4. PubMed ID: 21115246
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 11H-Isoquino[4,3-c]cinnolin-12-ones; novel anticancer agents with potent topoisomerase I-targeting activity and cytotoxicity.
    Ruchelman AL; Singh SK; Ray A; Wu X; Yang JM; Zhou N; Liu A; Liu LF; LaVoie EJ
    Bioorg Med Chem; 2004 Feb; 12(4):795-806. PubMed ID: 14759740
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents: a systematic study of structure-activity relationships.
    Kiselev E; Agama K; Pommier Y; Cushman M
    J Med Chem; 2012 Feb; 55(4):1682-97. PubMed ID: 22329436
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis of benzo[3,4]azepino[1,2-b]isoquinolin-9-ones from 3-arylisoquinolines via ring closing metathesis and evaluation of topoisomerase I inhibitory activity, cytotoxicity and docking study.
    Van HT; Khadka DB; Yang SH; Le TN; Cho SH; Zhao C; Lee IS; Kwon Y; Lee KT; Kim YC; Cho WJ
    Bioorg Med Chem; 2011 Sep; 19(18):5311-20. PubMed ID: 21873069
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex.
    Marchand C; Antony S; Kohn KW; Cushman M; Ioanoviciu A; Staker BL; Burgin AB; Stewart L; Pommier Y
    Mol Cancer Ther; 2006 Feb; 5(2):287-95. PubMed ID: 16505102
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Terbenzimidazoles: influence of 2"-, 4-, and 5-substituents on cytotoxicity and relative potency as topoisomerase I poisons.
    Kim JS; Yu C; Liu A; Liu LF; LaVoie EJ
    J Med Chem; 1997 Aug; 40(18):2818-24. PubMed ID: 9288163
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Indenoisoquinoline Topoisomerase Inhibitors Strongly Bind and Stabilize the
    Wang KB; Elsayed MSA; Wu G; Deng N; Cushman M; Yang D
    J Am Chem Soc; 2019 Jul; 141(28):11059-11070. PubMed ID: 31283877
    [No Abstract]   [Full Text] [Related]  

  • 56. Design and Synthesis of Indenoisoquinolines Targeting Topoisomerase I and Other Biological Macromolecules for Cancer Chemotherapy.
    Cushman M
    J Med Chem; 2021 Dec; 64(24):17572-17600. PubMed ID: 34879200
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure-activity studies of novel amidine analogues of chlorambucil: correlation of cytotoxic activity with DNA-binding affinity and topoisomerase II inhibition.
    Bielawska A; Bielawski K; Wołczyński S; Anchim T
    Arch Pharm (Weinheim); 2003 Aug; 336(6-7):293-9. PubMed ID: 12953217
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular design, synthesis and docking study of benz[b]oxepines and 12-oxobenzo[c]phenanthridinones as topoisomerase 1 inhibitors.
    Lee SH; Van HT; Yang SH; Lee KT; Kwon Y; Cho WJ
    Bioorg Med Chem Lett; 2009 May; 19(9):2444-7. PubMed ID: 19345580
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alcohol-, diol-, and carbohydrate-substituted indenoisoquinolines as topoisomerase I inhibitors: investigating the relationships involving stereochemistry, hydrogen bonding, and biological activity.
    Peterson KE; Cinelli MA; Morrell AE; Mehta A; Dexheimer TS; Agama K; Antony S; Pommier Y; Cushman M
    J Med Chem; 2011 Jul; 54(14):4937-53. PubMed ID: 21710981
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and docking studies of novel benzopyran-2-ones with anticancer activity.
    Ismail MM; Rateb HS; Hussein MM
    Eur J Med Chem; 2010 Sep; 45(9):3950-9. PubMed ID: 20580139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.